The store will not work correctly when cookies are disabled.
3,8a-di(pyridin-2-yl)indolizin-1(8aH)-one
ID: ALA4764540
PubChem CID: 149164754
Max Phase: Preclinical
Molecular Formula: C18H13N3O
Molecular Weight: 287.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C=C(c2ccccn2)N2C=CC=CC12c1ccccn1
Standard InChI: InChI=1S/C18H13N3O/c22-17-13-15(14-7-1-4-10-19-14)21-12-6-3-9-18(17,21)16-8-2-5-11-20-16/h1-13H
Standard InChI Key: WXWXZBZUSDQNOZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
3.6478 -3.4370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6466 -4.2632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3605 -4.6756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3587 -3.0248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0731 -3.4334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0779 -4.2632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8688 -4.5151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3527 -3.8408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8609 -3.1724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1108 -2.3873 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0682 -2.6090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7819 -2.1943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7773 -1.3707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0603 -0.9620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3465 -1.3829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3547 -2.2052 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1280 -5.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5785 -5.9123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8371 -6.6938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6447 -6.8609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1932 -6.2406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9318 -5.4615 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 2 0
5 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
7 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 287.32 | Molecular Weight (Monoisotopic): 287.1059 | AlogP: 2.68 | #Rotatable Bonds: 2 |
Polar Surface Area: 46.09 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.82 | CX LogP: 2.60 | CX LogD: 2.60 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: -0.09 |
References
1. Zhang JT,Wang LX,Yang FM,Yang L,Liu Y,Tang YL. (2021) Selective recognition of DNA parallel G-quadruplexes by 3,8a-disubstituted indolizinones., 29 [PMID:33189508] [10.1016/j.bmc.2020.115848] |